Clinical trial
The Belgian Endothelial Surgical Transplant of the Cornea:Clinical and Patient-reported Outcomes of Descemet Stripping Automated Endothelial Keratoplasty(DSAEK) Versus Descemet Membrane Endothelial Keratoplasty(DMEK)
NCT05436665 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Belgian Endothelial Surgical Transplant of the Cornea:Clinical and Patient-reported Outcomes of Descemet Stripping Automated Endothelial Keratoplasty(DSAEK) Versus Descemet Membrane Endothelial Keratoplasty(DMEK)
- Lead sponsor
- University Hospital, Antwerp
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- August 10, 2022
- Completion date
- June 6, 2028
- Enrollment
- 220 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
bullous keratopathy, corneal edema, corneal endothelial disorder, fuchs' endothelial dystrophy, pseudophakic bullous keratopathy